Xenon Pharmaceuticals
Top stories
Latest
- Xenon Pharmaceuticals (NASDAQ:XENE) CEO Purchases $1,121,400.00 in Stockthemarketsdaily.com · 2026-10-04 10:20 UTC · story
- Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)intelligencer.ca · 2026-10-02 20:03 UTC · story